{"cell_type":{"faa4f1b9":"code","8060eeee":"code","d163782a":"code","90c5acf5":"code","627dbd65":"code","e401b8f0":"code","8fbe5584":"code","4cada7b4":"code","93c4cd79":"code","9beff14b":"code","c923048c":"code","39be32ad":"code","9355dd21":"code","bd8aa123":"code","98cf4e0f":"code","adad90b8":"code","87437571":"code","e2b8d0cf":"code","ec09ffcd":"code","7ec783dd":"code","d221e060":"markdown","ea129db2":"markdown","132066b7":"markdown","0bddb9fb":"markdown","551c0ddc":"markdown","26138ac2":"markdown","7c72146f":"markdown","04165017":"markdown","49a79ae3":"markdown","96efeeab":"markdown"},"source":{"faa4f1b9":"#codes from Rodrigo Lima  @rodrigolima82\nfrom IPython.display import Image\nImage(url = 'https:\/\/encrypted-tbn0.gstatic.com\/images?q=tbn%3AANd9GcQgitX9824TSU4NOjlAVC4z5-3OzEP62VutdhkE6dtFaO6PQApm&usqp=CAU',width=400,height=400)","8060eeee":"# This Python 3 environment comes with many helpful analytics libraries installed\n# It is defined by the kaggle\/python Docker image: https:\/\/github.com\/kaggle\/docker-python\n# For example, here's several helpful packages to load\n\nimport numpy as np # linear algebra\nimport pandas as pd # data processing, CSV file I\/O (e.g. pd.read_csv)\nimport matplotlib.pyplot as plt\nimport seaborn as sns\nimport plotly.offline as py\nimport plotly.graph_objs as go\nimport plotly.offline as py\nimport plotly.express as px\n\n# Input data files are available in the read-only \"..\/input\/\" directory\n# For example, running this (by clicking run or pressing Shift+Enter) will list all files under the input directory\n\nimport os\nfor dirname, _, filenames in os.walk('\/kaggle\/input'):\n    for filename in filenames:\n        print(os.path.join(dirname, filename))\n\n# You can write up to 5GB to the current directory (\/kaggle\/working\/) that gets preserved as output when you create a version using \"Save & Run All\" \n# You can also write temporary files to \/kaggle\/temp\/, but they won't be saved outside of the current session","d163782a":"df = pd.read_csv('..\/input\/cusersmarildownloadstcellcsv\/TCell.csv', sep=';')\ndf","90c5acf5":"fig,axes = plt.subplots(1,1,figsize=(20,5))\nsns.heatmap(df.isna(),yticklabels=False,cbar=False,cmap='viridis')\nplt.show()","627dbd65":"fig = go.Figure();\nfig.add_trace(go.Scatter(x = df['age_at_enrollment'].head(10),y = df['study_id'],\n                    mode='lines+markers',\n                    name='study_id'));\nfig.add_trace(go.Scatter(x = df['age_at_enrollment'].head(10),y = df['sex'],\n                    mode='lines+markers',\n                    name='sex'));\nfig.add_trace(go.Scatter(x = df['age_at_enrollment'].head(10),y = df['dm'],\n                    mode='lines+markers',\n                    name='dm'));\nfig.add_trace(go.Scatter(x = df['age_at_enrollment'].head(10),y = df['htn'],\n                    mode='lines+markers',\n                    name='htn'));\nfig.add_trace(go.Scatter(x = df['age_at_enrollment'].head(10),y = df['anemia'],\n                    mode='lines+markers',\n                    name='anemia'));\n\nfig.update_traces(mode='lines+markers', marker_line_width=2, marker_size=10);\n\nfig.update_layout(autosize=False, width=1000,height=700, legend_orientation=\"h\");\n\nfig.show();","e401b8f0":"fig = px.pie(df,\n             values=\"cd4\",\n             names=\"dlco_percent_pred\",\n             template=\"seaborn\")\nfig.update_traces(rotation=90, pull=0.05, textinfo=\"percent+label\")\nfig.show()","8fbe5584":"fig = px.treemap(df, path=['study_id'], values='age_at_enrollment',\n                  color='age_at_enrollment', hover_data=['study_id'],\n                  color_continuous_scale='Rainbow')\nfig.show()","4cada7b4":"!pip install chart_studio","93c4cd79":"pip install bubbly","9beff14b":"from bubbly.bubbly import bubbleplot \nfrom plotly.offline import iplot\nimport chart_studio.plotly as py\n\nfigure = bubbleplot(dataset=df, x_column='cd4', y_column='study_id', \n    bubble_column='age_at_enrollment',size_column='htn', color_column='age_at_enrollment', \n    x_title=\"CD4 Lymphocyte\", y_title=\"Study ID\", title='CD4 Lymphocyte Study ID',\n     scale_bubble=3, height=650)\n\niplot(figure, config={'scrollzoom': True})","c923048c":"ax = df.plot(figsize=(15,8), title='CD4 Lymphocyte Study')\nax.set_xlabel('age_at_enrollment, sex, dm, htn')\nax.set_ylabel('study_id')","39be32ad":"df.iloc[0]","9355dd21":"df.plot.hist()","bd8aa123":"df.plot.scatter(x = 'study_id', y = 'cd4', c = 'htn', s = 190)","98cf4e0f":"df.plot.hexbin(x = 'age_at_enrollment', y = 'cd4', gridsize = 5, C = 'htn')","adad90b8":"plt.style.use('dark_background')\nfrom pandas.plotting import scatter_matrix\nscatter_matrix(df, figsize= (8,8), diagonal='kde', color = 'b')\nplt.xticks(rotation=45)\nplt.yticks(rotation=45)\nplt.show()","87437571":"plt.style.use('dark_background')\ndfcorr=df.corr()\ndfcorr\nplt.figure(figsize=(10,4))\nsns.heatmap(df.corr(),annot=False,cmap='summer')\nplt.show()","e2b8d0cf":"bboxtoanchor=(1.1, 1.05)\nplt.style.use('dark_background')\ndf.plot.area(y=['study_id','age_at_enrollment','sex', 'dm', 'htn', 'anemia', 'chronic_heart_disease', 'tb', 'pcp', 'pneu', 'ART_use'],alpha=0.4,figsize=(12, 6));","ec09ffcd":"from IPython.display import IFrame\nIFrame('https:\/\/app.powerbi.com\/view?r=eyJrIjoiMjcxNDIyNjAtOGM0Yi00ZWJhLWJkNmEtNjFiOTI0MWVlYjNiIiwidCI6IjI1NmNiNTA1LTAzOWYtNGZiMi04NWE2LWEzZTgzMzI4NTU3OCIsImMiOjh9', width=800, height=500)","7ec783dd":"#codes from Rodrigo Lima  @rodrigolima82\nfrom IPython.display import Image\nImage(url = 'data:image\/png;base64,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',width=400,height=400)","d221e060":"#Codes from Sanket Parate https:\/\/www.kaggle.com\/sanketparate5\/data-visualization-with-pandas","ea129db2":"The researchers identified a CD4 and CD8 lymphocyte response in individuals not exposed to Sars-Cov-2, which indicates cross-reactions with other respiratory coronaviruses. And cellular responses in convalescent patients have a good correlation with neutralizing antibodies. This will be instrumental in the development of an effective vaccine.\n\nThey saw a potent reaction to the presence of protein S from the virus, which is used by him to invade human cells. It is good news for vaccine development.\n\nThere is \"strong evidence that there is a difference in the response of the defense cells of people who had Covid-19 from those who did not even show symptoms\". The response of lymphocytes from blood samples collected is investigated between 2015 and 2018, before Sars-CoV-2 entered into circulation. These lymphocytes reacted fiercely to the new coronavirus, although they had never been exposed to it.\n\nThe cross reaction with other coronaviruses is the possible explanation for the non-illness in most of the population. The most interesting thing is that it is perhaps more important than neutralizing antibodies.  https:\/\/translate.google.com.br\/translate?hl=en&sl=pt&u=https:\/\/oglobo.globo.com\/sociedade\/memoria-imunologica-peca-chave-na-protecao-contra-covid-19-indicam-estudos-24444812&prev=search","132066b7":"icar2019.it","0bddb9fb":"German research by the University of Berlin and the Max Planck Institute for Molecular Genetics has shown cross-reactivity to other coronaviruses in lymphocytes from patients with Covid-19 and in uninfected people.\n\nThe study points out that CD4 and CD8 cells \u201ccan be crucial to understand the very different manifestations of Sars-CoV-2 infection and, in particular, the high rate of asymptomatic and children and young adults with milder conditions. Since these, in general, have more social contacts than the elderly and, therefore, they could be more infected by the other coronaviruses. https:\/\/translate.google.com.br\/translate?hl=en&sl=pt&u=https:\/\/oglobo.globo.com\/sociedade\/memoria-imunologica-peca-chave-na-protecao-contra-covid-19-indicam-estudos-24444812&prev=search","551c0ddc":"Kaggle Notebook Runner: Mar\u00edlia Prata  @mpwolke","26138ac2":"#Code from Firat Gonen  https:\/\/www.kaggle.com\/frtgnn\/world-population-visuals","7c72146f":"#Cross-Reaction\n\nAnother four coronaviruses are very common and cause about 20% of respiratory infections. Known only by the acronyms 229E, NL63, OC43 and HKU1, they are widespread in the world. It is estimated that anyone has had contact with the four or at least three of them, which explains the cross reaction of the defense cells of someone who is infected with Sars-Cov-2. They would \u201cremember\u201d them.\n\nAccording to researchers at the University of Berlin, an adult could contract infection with one of these coronaviruses on average every two or three years. As they do not evolve severely in the overwhelming majority of cases, people are only given the vague diagnosis of \"a virus\". \nIt is not yet known to what extent the cross-reaction could offer immunity, for how long it would last and even if it is more frequent in some regions of the world. https:\/\/translate.google.com.br\/translate?hl=en&sl=pt&u=https:\/\/oglobo.globo.com\/sociedade\/memoria-imunologica-peca-chave-na-protecao-contra-covid-19-indicam-estudos-24444812&prev=search","04165017":"pinterest.ca","49a79ae3":"#CD4\n\nIn molecular biology, CD4 (cluster of differentiation 4) is a glycoprotein found on the surface of immune cells such as T helper cells, monocytes, macrophages, and dendritic cells. It was discovered in the late 1970s and was originally known as leu-3 and T4 (after the OKT4 monoclonal antibody that reacted with it) before being named CD4 in 1984. In humans, the CD4 protein is encoded by the CD4 gene.https:\/\/en.wikipedia.org\/wiki\/CD4 \n\n#CD8\n\nCD8 (cluster of differentiation 8) is a transmembrane glycoprotein that serves as a co-receptor for the T-cell receptor (TCR). Along with the TCR, the CD8 co-receptor plays a role in T cell signaling and aiding with cytotoxic T cell antigen interactions. \nLike the TCR, CD8 binds to a major histocompatibility complex (MHC) molecule, but is specific for the MHC class I protein.[1] \nThere are two isoforms of the protein, alpha and beta, each encoded by a different gene. In humans, both genes are located on chromosome 2 in position 2p12 https:\/\/en.wikipedia.org\/wiki\/CD8","96efeeab":"#The CD4+\/CD8+ ratio\n\nThe CD4+\/CD8+ ratio is the ratio of T helper cells (with the surface marker CD4) to cytotoxic T cells (with the surface marker CD8). Both CD4+ and CD8+ T cells contain several subsets.\n\nThe CD4+\/CD8+ ratio in the peripheral blood of healthy adults and mice is about 2:1, and an altered ratio can indicate diseases relating to immunodeficiency or autoimmunity. An inverted CD4+\/CD8+ ratio (namely, less than 1\/1) indicates an impaired immune system. \n\nBoth effector helper T cells (Th1 and Th2) and regulatory T cells (Treg) cells have a CD4 surface marker, such that although total CD4+ T cells decrease with age, the relative percent of CD4+ T cells increases. The increase in Treg with age results in suppressed immune response to infection, vaccination, and cancer, without suppressing the chronic inflammation associated with aging https:\/\/en.wikipedia.org\/wiki\/CD4%2B\/CD8%2B_ratio"}}